secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vicarious Surgical Inc. (RBOT)
CIK:        0001812173
Form:       8-K
Filed at:   2023-07-27T23:59:59+00:00
Accession:  0001213900-23-060258
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vicarious Surgical Q2 2023 net loss $15.3M; expects first human procedure mid-2024
--------------------------------------------------------------------------------

- GAAP net loss $15.3M ($0.12/sh) vs $1.5M ($0.01/sh) YoY; adjusted net loss $20.4M ($0.16/sh).
- Cash and investments $82.8M; quarterly burn $14.9M; FY 2023 cash burn guidance $55-$65M unchanged.
- FDA clarity on regulatory pathway; first ventral hernia procedure planned for mid-2024.
- Design freeze of V1.0 system completed April; integration on track for fall 2023.
- Signed fourth major U.S. hospital system agreement, covering over 250 hospitals; promoted John Mazzola to COO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812173/000121390023060258/0001213900-23-060258-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812173/000121390023060258/ea182423-8k_vicarious.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-060258

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer